Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10883854 | 0.97 | TSHR (0.54) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL26740108 | 0.94 | TSHR (0.61) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL10890672 | 0.92 | TSHR (0.59) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL17069795 | 0.92 | TSHR (0.53) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL10659632 | 0.91 | TSHR (0.58) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL14175495 | 0.91 | TSHR (0.55) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL9763730 | 0.89 | TSHR (0.50) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL13561215 | 0.88 | TSHR (0.54) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL9764152 | 0.88 | TSHR (0.52) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL12131528 | 0.86 | TSHR (0.59) | TSHRALDH1A1TP53HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4476282-A1 | COMPOSITIONS AND METHODS FOR COMPATIBILIZING POLYOLEFINS | Rockytech, Ltd. (US) | 2024-12-18 | — | — | EP | claimed |
| CN-118647651-A | Compositions and methods for compatibilizing polyolefins | 落基科技股份有限公司 | 2024-09-13 | — | — | CN | claimed |
| WO-2023154106-A1 | COMPOSITIONS AND METHODS FOR COMPATIBILIZING POLYOLEFINS | ROCKYTECH, LTD. (US) | 2023-08-17 | — | — | WO | claimed |
| WO-2026099089-A1 | PATTERN-CONTROLLED SURFACE RELIEF STRUCTURES COMPRISING LIQUID CRYSTALS | BASF SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4734929-A1 | SYSTEM AND METHODS FOR MODIFYING SURFACE PROPERTIES OF KERATIN-CONTAINING SURFACES | Edulis Labs Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260103612-A1 | OVER-PRINT VARNISH FORMULATION | HEWLETT PACKARD DEVELOPMENT CO (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260036718-A1 | CONTACT LENS COMPOSITION AND CONTACT LENS PRODUCT | LARGAN MEDICAL CO LTD (TW) | 2026-02-05 | — | — | US | disclosed |
| EP-4686405-A1 | CONTACT LENS COMPOSITION AND CONTACT LENS PRODUCT | Largan Medical Co., Ltd. (TW) | 2026-02-04 | — | — | EP | disclosed |
| WO-2025245116-A1 | INJECTABLE AND MOLDABLE ELASTOMERS AND MEDICAL DEVICES | VATANKHAH VARNOSFADERANI MOHAMMAD (US) | 2025-11-27 | — | — | WO | disclosed |
| US-12460096-B2 | Over-print varnish formulation | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12442956-B2 | Contact lens product | LARGAN MEDICAL CO., LTD. (TW) | 2025-10-14 | — | — | US | disclosed |
| US-11319454-B2 | Polyurethane-based binder dispersion | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-05-03 | — | — | US | disclosed |
| WO-2022051762-A2 | NON-LEACHING WATERBORNE VIRUCIDAL/BACTERICIDAL COATING | CURRAN BIOTECH INC. (US) | 2022-03-10 | — | — | WO | disclosed |
| US-8492513-B2 | Method for enhancing water content of silicone hydrogel contact lens | FAR EASTERN NEW CENTURY CORPORATION (TW) | 2013-07-23 | — | — | US | disclosed |
| US-20120214898-A1 | SILICONE HYDROGEL WITH HIGH WATER CONTENT | FAR EASTERN NEW CENTURY CORPORATION (TW) | 2012-08-23 | — | — | US | disclosed |
| US-20120214899-A1 | METHOD FOR ENHANCING WATER CONTENT OF SILICONE HYDROGEL CONTACT LENS | FAR EASTERN NEW CENTURY CORPORATION (TW) | 2012-08-23 | — | — | US | disclosed |
| US-20120115979-A1 | CHLORINATED POLYMER ENHANCING WETTABILITY OF SILICONE HYDROGEL, SILICONE HYDROGEL COMPRISING THE SAME AND OCULAR ARTICLE MADE THEREFROM | FAR EASTERN NEW CENTURY CORPORATION (TW) | 2012-05-10 | — | — | US | disclosed |
| US-7906563-B2 | Polysiloxane-based prepolymer and hydrogel | FAR EASTERN NEW CENTURY CORPORATION (TW) | 2011-03-15 | — | — | US | disclosed |
| US-20090170976-A1 | Polysiloxane-based prepolymer and hydrogel | FAR EASTERN TEXTILE LTD. | 2009-07-02 | — | — | US | disclosed |
| US-4743667-A | ACRYLATED SILOXXANES, OXYGEN PERMEABLE | NIPPON CONTACT LENS, INC. (JP) | 1988-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103612-A1 | OVER-PRINT VARNISH FORMULATION | PUF60, U2SURP, VMP1 | TSHR 2815/4885ALDH1A1 2853/4885TP53 1543/4885 |
| US-20260036718-A1 | CONTACT LENS COMPOSITION AND CONTACT LENS PRODUCT | CRYAB, CRYZ, RPL5 | TSHR 3452/4885ALDH1A1 3369/4885TP53 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.